• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌综述:流行病学、病因学与致癌机制

Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.

作者信息

Ghouri Yezaz Ahmed, Mian Idrees, Rowe Julie H

机构信息

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston, Texas, USA.

Department of Hematology and Oncology, National Institute of Health, Bethesda, Maryland, USA.

出版信息

J Carcinog. 2017 May 29;16:1. doi: 10.4103/jcar.JCar_9_16. eCollection 2017.

DOI:10.4103/jcar.JCar_9_16
PMID:28694740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5490340/
Abstract

Since the 1970s, the epidemic of hepatocellular carcinoma (HCC) has spread beyond the Eastern Asian predominance and has been increasing in Northern hemisphere, especially in the United States (US) and Western Europe. It occurs more commonly in males in the fourth and fifth decades of life. Among all cancers, HCC is one of the fastest growing causes of death in the US and poses a significant economic burden on healthcare. Chronic liver disease due to hepatitis B virus or hepatitis C virus and alcohol accounts for the majority of HCC cases. Incidence of nonalcoholic fatty liver disease has been on the risem and it has also been associated with the development of HCC. Its pathogenesis varies based on the underlying etiological factor although majority of cases develop in the setting of background cirrhosis. Carcinogenesis of HCC includes angiogenesis, chronic inflammation, and tumor macroenvironment and microenvironment. There is a significant role of both intrinsic genetic risk factors and extrinsic influences such as alcohol or viral infections that lead to the development of HCC. Understanding its etiopathogenesis helps select appropriate diagnostic tests and treatments.

摘要

自20世纪70年代以来,肝细胞癌(HCC)的流行已超出东亚地区的主导范围,在北半球呈上升趋势,尤其是在美国和西欧。它更常见于40至50岁的男性。在所有癌症中,HCC是美国增长最快的死亡原因之一,给医疗保健带来了巨大的经济负担。乙型肝炎病毒或丙型肝炎病毒以及酒精导致的慢性肝病占大多数HCC病例。非酒精性脂肪性肝病的发病率一直在上升,它也与HCC的发生有关。尽管大多数病例是在背景性肝硬化的情况下发生的,但其发病机制因潜在的病因因素而异。HCC的致癌过程包括血管生成、慢性炎症以及肿瘤的宏观和微观环境。内在遗传风险因素和外在影响因素(如酒精或病毒感染)在HCC的发生发展中都起着重要作用。了解其病因发病机制有助于选择合适的诊断测试和治疗方法。

相似文献

1
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.肝细胞癌综述:流行病学、病因学与致癌机制
J Carcinog. 2017 May 29;16:1. doi: 10.4103/jcar.JCar_9_16. eCollection 2017.
2
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
3
Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma.病毒性肝炎、非酒精性脂肪性肝病及酒精作为肝细胞癌的危险因素。
Chin Clin Oncol. 2013 Dec;2(4):32. doi: 10.3978/j.issn.2304-3865.2013.09.02.
4
Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.乙型肝炎病毒编码蛋白及其在肝癌发展中的慢性感染的直接作用。
Dig Dis. 2013;31(1):138-51. doi: 10.1159/000347209. Epub 2013 Jun 17.
5
Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.从 1998 年到 2015 年的真实世界经验:肝细胞癌患者的疾病表现和生存的时间趋势。
Cancer. 2018 Jun 15;124(12):2588-2598. doi: 10.1002/cncr.31373. Epub 2018 Apr 6.
6
Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.肝细胞癌:流行病学、发病机制与监测——对撒哈拉以南非洲地区的影响
S Afr Med J. 2018 Aug 8;108(8b):35-40. doi: 10.7196/SAMJ.2018.v108i8b.13499.
7
Disease Burden of Hepatocellular Carcinoma: A Global Perspective.肝癌疾病负担:全球视角。
Dig Dis Sci. 2019 Apr;64(4):910-917. doi: 10.1007/s10620-019-05537-2.
8
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.非酒精性脂肪性肝炎是肝移植候选者中肝细胞癌增长最快的病因。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14.
9
[Role of environmental factors in the etiology of hepatocellular carcinoma].[环境因素在肝细胞癌病因学中的作用]
Orv Hetil. 2010 Jul 11;151(28):1132-6. doi: 10.1556/OH.2010.28913.
10
Chronic hepatitis B virus infection in Asian countries.亚洲国家的慢性乙型肝炎病毒感染
J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x.

引用本文的文献

1
Modern approach to hepatocellular carcinoma treatment.肝细胞癌治疗的现代方法。
World J Hepatol. 2025 Aug 27;17(8):107873. doi: 10.4254/wjh.v17.i8.107873.
2
Towards eliminating hepatocellular carcinoma from Aotearoa New Zealand: a nationally coordinated programme to detect and treat chronic hepatitis?在新西兰消除肝细胞癌:一项全国协调的慢性肝炎检测与治疗计划?
J R Soc N Z. 2025 May 7;55(5):1209-1221. doi: 10.1080/03036758.2025.2491511. eCollection 2025.
3
Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence.放射治疗、靶向治疗和免疫治疗与肝细胞癌复发的相关性
World J Gastrointest Oncol. 2025 Jul 15;17(7):107815. doi: 10.4251/wjgo.v17.i7.107815.
4
Spatial multi-omics and deep learning reveal fingerprints of immunotherapy response and resistance in hepatocellular carcinoma.空间多组学与深度学习揭示肝细胞癌免疫治疗反应和耐药的特征
bioRxiv. 2025 Jun 12:2025.06.11.656869. doi: 10.1101/2025.06.11.656869.
5
Radiomic features on contrast-enhanced images of the remnant liver predict the prognosis of hepatocellular carcinoma after partial hepatectomy.残余肝脏对比增强图像上的放射组学特征可预测肝癌肝部分切除术后的预后。
ILIVER. 2024 Feb 6;3(1):100079. doi: 10.1016/j.iliver.2024.100079. eCollection 2024 Mar.
6
Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma.立体定向体部放射治疗(SBRT)通过增强转移性肝细胞癌小鼠的肿瘤免疫微环境来提高抗PD-1抗肿瘤活性。
Discov Oncol. 2025 Jun 13;16(1):1081. doi: 10.1007/s12672-025-02914-4.
7
Gut Microbiota and the Gut-Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies.肠道微生物群与肝脏疾病中的肠-肝轴:从慢性病毒性肝炎到肝硬化、肝细胞癌及基于微生物群的治疗方法
Microorganisms. 2025 Apr 30;13(5):1053. doi: 10.3390/microorganisms13051053.
8
Expression of miR-15b-5p and toll-like receptor4 as potential novel diagnostic biomarkers for hepatitis C virus-induced hepatocellular carcinoma.miR-15b-5p和Toll样受体4作为丙型肝炎病毒诱导的肝细胞癌潜在新型诊断生物标志物的表达
Noncoding RNA Res. 2024 Dec 15;10:262-268. doi: 10.1016/j.ncrna.2024.12.003. eCollection 2025 Feb.
9
DPP4, a potential tumor biomarker, and tumor therapeutic target: review.二肽基肽酶4(DPP4),一种潜在的肿瘤生物标志物和肿瘤治疗靶点:综述
Mol Biol Rep. 2025 Jan 16;52(1):126. doi: 10.1007/s11033-025-10235-6.
10
Regulatory role of lnc-MAP3K13-3:1 on miR-6894-3p and SHROOM2 in modulating cellular dynamics in hepatocellular carcinoma.lnc-MAP3K13-3:1对miR-6894-3p和SHROOM2在调节肝细胞癌细胞动力学中的调控作用。
BMC Cancer. 2025 Jan 14;25(1):83. doi: 10.1186/s12885-024-13263-w.

本文引用的文献

1
The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.乙型肝炎病毒前S2缺失突变蛋白在HBV肿瘤发生中的新作用。
J Biomed Sci. 2014 Oct 15;21(1):98. doi: 10.1186/s12929-014-0098-7.
2
Diverse modes of genomic alteration in hepatocellular carcinoma.肝细胞癌基因组改变的多种模式。
Genome Biol. 2014 Aug 26;15(8):436. doi: 10.1186/s13059-014-0436-9.
3
Emerging trends in hepatocellular carcinoma incidence and mortality.肝细胞癌发病率和死亡率的新趋势。
Hepatology. 2015 Jan;61(1):191-9. doi: 10.1002/hep.27388. Epub 2014 Nov 24.
4
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.美国丙型肝炎病毒感染患者队列中乙型肝炎病毒合并感染的临床结局。
Hepatology. 2014 Dec;60(6):1871-8. doi: 10.1002/hep.27337. Epub 2014 Oct 29.
5
Strategies to manage hepatitis C virus (HCV) disease burden.管理丙型肝炎病毒 (HCV) 疾病负担的策略。
J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.
6
Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.乙型肝炎和丁型肝炎病毒进入限制的分子决定因素在小鼠牛磺胆酸钠共转运多肽中。
J Virol. 2013 Jul;87(14):7977-91. doi: 10.1128/JVI.03540-12. Epub 2013 May 15.
7
Epidemiology of hepatocellular carcinoma: consider the population.肝细胞癌的流行病学:从人群角度考虑。
J Clin Gastroenterol. 2013 Jul;47 Suppl(0):S2-6. doi: 10.1097/MCG.0b013e3182872f29.
8
Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.微环境在肝细胞癌发病机制和治疗中的作用。
Gastroenterology. 2013 Mar;144(3):512-27. doi: 10.1053/j.gastro.2013.01.002. Epub 2013 Jan 9.
9
Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.对肝细胞癌患者乙型肝炎病毒的深度测序揭示了丰富的整合事件、结构改变和序列变异。
Carcinogenesis. 2013 Apr;34(4):787-98. doi: 10.1093/carcin/bgs406. Epub 2012 Dec 30.
10
Comprehensive genome sequencing of the liver cancer genome.全面的肝癌基因组测序。
Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8.